US Clinical Laboratory Services Market to Reach USD 13.99 Billion by 2032, Growing at a CAGR of 5.08% During 2026–2032

The US Clinical Laboratory Services Market was valued at USD 9.89 billion in 2025 and is projected to increase from USD 10.39 billion in 2026 to USD 13.99 billion by 2032, expanding at a CAGR of 5.08% during the forecast period. Market growth is being supported by rising diagnostic testing volumes, increasing demand for preventive healthcare services, and the growing need for routine disease monitoring across healthcare settings. The expanding utilization of laboratory diagnostics across chronic disease management, precision medicine, and population health initiatives continues to strengthen the industry's long-term outlook.

A major factor supporting market expansion is the growing burden of chronic diseases across the United States. According to data cited in the research, approximately 194 million American adults are living with one or more chronic conditions, creating sustained demand for blood chemistry testing, pathology services, genetic analysis, and infectious disease diagnostics.

From a segmentation perspective, genetic testing emerged as the leading test type segment, driven by growing demand for hereditary disease screening, oncology biomarker analysis, and personalized treatment approaches. Meanwhile, stand-alone laboratories dominated the service provider landscape with a 46.3% market share due to their extensive diagnostic networks, advanced automation capabilities, operational efficiency, and nationwide accessibility. Continuous investments in molecular diagnostics, laboratory automation, and specialized testing services are expected to reinforce the leadership of these segments throughout the forecast period.

Regionally, the market demonstrates strong growth opportunities across multiple geographies, with the South accounting for the largest market share at 35.4%, supported by a large patient population, expanding healthcare infrastructure, increasing disease burden, and robust demand for diagnostic testing services. At the same time, regions with advanced laboratory infrastructure and strong research capabilities continue to contribute significantly to market development. Ongoing technological advancements, growing investments in precision diagnostics, and expanding healthcare access are expected to sustain growth across the US clinical laboratory services industry through 2032, further stated in recent report “US Clinical Laboratory Services Market Analysis, 2026”.

US Clinical Laboratory Services Market Highlights

The US clinical laboratory services market is valued at USD 9.89 billion in 2025, rising to USD 10.39 billion in 2026, and is projected to reach USD 13.99 billion by 2032, expanding at a CAGR of 5.08%.
Stand-alone laboratories lead the service provider segment with a 46.3% market share, supported by extensive testing capabilities, nationwide accessibility, operational efficiency, and growing outsourcing of diagnostic services.
Genetic testing dominates the test type segment with a 24.8% share, driven by increasing adoption of precision medicine, hereditary disease screening, oncology diagnostics, and advancements in molecular testing technologies.
The South region accounts for the largest market share at 35.4%, supported by a large patient population, expanding healthcare infrastructure, increasing disease burden, and strong diagnostic testing demand.
The market is moderately consolidated, with the top five participants collectively accounting for approximately 35% of total market revenue.

US Clinical Laboratory Services Market Segmentation

By Test Type

Genetic Testing
Clinical Chemistry
- Routine Chemistry Testing
- Therapeutic Drug Monitoring Testing
- Endocrinology Chemistry Testing
- Specialized Chemistry Testing
- Other Clinical Chemistry Testing
Medical Microbiology Testing
- Infectious Disease Testing
- Transplant Diagnostic Testing
- Other Microbiology Testing
Hematology Testing
Immunology Testing
Cytology Testing
Drug of Abuse Testing
Other Esoteric Tests